tradingkey.logo
tradingkey.logo
Search

Prophase Labs Inc

PRPH
Add to Watchlist
0.363USD
0.0000.00%
Close 07/02, 13:00ETQuotes delayed by 15 min
1.09MMarket Cap
LossP/E TTM

More Details of Prophase Labs Inc Company

ProPhase Labs, Inc. is a biotech, genomics, and consumer products company. The Company is engaged in providing whole genome sequencing solutions, diagnostic development, such as its potentially life-saving test for the early detection of esophageal cancer and a direct-to-consumer marketing platform for OTC dietary supplements. It develops, manufactures, and commercializes health and wellness solutions. Its Diagnostic services segment provides diagnostic information services to a range of customers in the United States, including health plans, third-party payers and government organizations. Its Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and provides personal genomics products and services. The Company also develops and markets dietary supplements under the TK Supplement brand, which includes Legendz XL and Triple Edge XL.

Prophase Labs Inc Info

Ticker SymbolPRPH
Company nameProphase Labs Inc
IPO dateJan 16, 1984
CEOKarkus (Ted William)
Number of employees96
Security typeOrdinary Share
Fiscal year-endJan 16
Address711 Stewart Ave, Suite 200
CityNEW YORK
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code11530
Phone12153450919
Websitehttps://www.prophaselabs.com/
Ticker SymbolPRPH
IPO dateJan 16, 1984
CEOKarkus (Ted William)

Company Executives of Prophase Labs Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Ted William Karkus
Mr. Ted William Karkus
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
321.53K
--
Dr. Louis Gleckel, M.D.
Dr. Louis Gleckel, M.D.
Independent Director
Independent Director
10.38K
--
Mr. Warren Hirsch, CPA
Mr. Warren Hirsch, CPA
Independent Director
Independent Director
--
--
Ms. Carolina Abenante, Esq.
Ms. Carolina Abenante, Esq.
Independent Director
Independent Director
--
--
Mr. Steven M. Plumb, CPA
Mr. Steven M. Plumb, CPA
Fractional Chief Financial Officer
Fractional Chief Financial Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Ted William Karkus
Mr. Ted William Karkus
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
321.53K
--
Dr. Louis Gleckel, M.D.
Dr. Louis Gleckel, M.D.
Independent Director
Independent Director
10.38K
--
Mr. Warren Hirsch, CPA
Mr. Warren Hirsch, CPA
Independent Director
Independent Director
--
--
Ms. Carolina Abenante, Esq.
Ms. Carolina Abenante, Esq.
Independent Director
Independent Director
--
--
Mr. Steven M. Plumb, CPA
Mr. Steven M. Plumb, CPA
Fractional Chief Financial Officer
Fractional Chief Financial Officer
--
--

FAQs

Who are the top five shareholders of Prophase Labs Inc?

The top five shareholders of Prophase Labs Inc are: Mr. Ted William Karkus

How many institutions hold shares of Prophase Labs Inc (PRPH)?

As of 2026Q1, 81 institutions hold shares of Prophase Labs Inc, with a combined market value of approximately 129.97K, accounting for 1.98% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -543519.00.